openPR Logo
Press release

Research on Transfection Technology (Instruments & Reagents) Market Forecast and Analysis Till 2021

02-01-2017 10:11 AM CET | Health & Medicine

Press release from: SA-BRC

Research on Transfection Technology (Instruments & Reagents)

Transfection is a very popular tool in biotechnology for genetic and molecular biology applications and involves the deliberate introduction of nucleic acids into eukaryotic cells. Through the years, transfection along with other genetic material transfer technologies have improved dramatically. Transfection has been applied in many research areas of drug discovery and development. The process is frequently complex since no single delivery method or transfection reagent can be applied to all types of cells.

This report focuses on the market of transfection instruments and reagents across North America, Europe, Asia-Pacific, Latin America, Middle-East and Africa. The research entails market sizing and forecast by chemical/biochemical methods such as Lipofection, Cationic Lipid Transfection, Calcium Phosphate, DEAE and Activated Dendrimers. Instrument based methods include Electroporation, Sonoporation, Magnet-Assisted, Biolistics, Microinjections or Nucleoinjections, and Laserfection or Optoinjection. Other methods also include viral techniques used for cell-types that are resistant to lipid-mediated transfection. Virus mediated transfection include the use of a variety of vectors such as Adenoviral, oncoretroviral, and lentiviral vectors and baculovirus and vaccinia virus-based vectors.

Free Sample Report@ http://www.sa-brc.com/Global-Transfection-Technology-Instruments--Reagents-Market-Assessment--Forecast-2017-2021/up73

The transfection technology market is very dynamic due to the range of options available for applications and end-users. The techniques are employed primarily in the field of research and development in pharmaceuticals and personalized medicine. It is used for research in gene expression studies, cancer research, research of infectious diseases such as herpes and hepatitis. In 2017, MaxCyte, Inc. a developer and supplier of cell engineering products and technologies highlighted positive pre-clinical results from a collaborative study with investigators at the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) on X-linked chronic granulomatous disease.

There are other veteran players operating in the transfection technology market include ThermoFisher Scientific, Qiagen, Takara-Clontech, Cellular Dynamics, Genlantis, Altogen, Bio-Rad, Hoffman La Roche, Promega Corporation, Lonza Group, Archimed, Mirus Bio, Tecrea Ltd and smaller innovative companies such as Lipocalyx GmbH. The global transfection technology market is highly fragmented with major players in biotechnology leading this segment. However, growth of investment across unconventional economically important countries such as China, India and others in South-East Asia will provide significant stimulus to growth of domestic players. New opportunities and new entrants seem to abound as mergers and acquisitions are currently being observed to spike. In January, 2017 Bruker acquired German InVivo Biotech Services GmbH. InVivo Biotech provides a complete range of biotech services, from cloning, screening and recombinant expression of antigens to the generation of hybridoma cell lines, and from characterization of antibodies to final production of the developed monoclonal antibodies.

Click For TOC@ http://www.sa-brc.com/Global-Transfection-Technology-Instruments--Reagents-Market-Assessment--Forecast-2017-2021/upcomingdetail73

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701
Email: sales@sa-brc.com
Website: www.sa-brc.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Research on Transfection Technology (Instruments & Reagents) Market Forecast and Analysis Till 2021 here

News-ID: 425931 • Views:

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-2021
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2021
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases


More Releases for Transfection

Transfection Market: A Comprehensive Analysis
The transfection market has gained significant traction in recent years due to advancements in genetic research and biotechnology. Transfection is a process of introducing nucleic acids, such as DNA or RNA, into cells to study gene expression, develop gene therapies, and conduct research in molecular biology. The rising demand for gene therapy, cancer research, and regenerative medicine is driving the expansion of the transfection market. The growing adoption of advanced
Transfection Technologies Market 2022 | Growing Transfection Reagent and Equipme …
According to Precision Business Insights (PBI), the latest report, the transfection technologies market is expected to be worth USD 1023.8 million in 2022, growing at an 8.9% CAGR from 2022 to 2028. The primary driver of the expansion of the global transfection technologies market includes advances in cell research technologies and therapeutic deliveries, a rise in funding for research and development in transfection technology by government and private firms, the
Transfection Technologies Market Size, Growth (2021-2028) | Top Key Vendors – …
The overall Transfection Technologies market is uncommonly ferocious. To keep up their position and drive the market improvement, industry players are persistently improving and searching for market expansion logically through progressions, thing dispatches, solidifications and acquisitions, sagacious portfolio, and growing interests in R&D. Moreover, they are in like manner acquiring various firms and contributing on internal creative work. Through these frameworks, the business players are expanding their certification watching out,
Transfection Technologies Market Emerging Growth Factors with Top Industry Playe …
The Transfection Technologies Market research report encourage businesses with the intelligent decision making and better manage marketing of goods which ultimately leads to growth and success. This market report encompasses six major parameters namely market analysis, market definition, market segmentation, key developments in the market, competitive analysis, and research methodology. It indicates that the rise in market value is generally attributed to the rising growth of the applicable industries and
Transfection Reagents and Equipment Market 2025 | Hoffmann-La Roche Ltd., Promeg …
San Francisco, California, Aug 23, 2019: TMR Research states that global transfection reagents and equipment market will see a witness major developments in the coming years. Transfection is one of the key research efforts leading the studies in synthetic genetics. While transfections can result in the formation of abnormal cells and unpredictable morphologies, the process can also be used to study the formation of genetic make-up and to transform cell
Transfection Reagents and Equipment Market - Performance Survey 2025 | Polyplus- …
Global Transfection Reagents and Equipment Market: Snapshot Transfection involves the conscious introduction of nucleic acid molecules into eukaryotic cells. Some of the most common examples of transfection include introducing DNA plasmids possessing gene inserts for expression and small interfering RNA (siRNA). The transfection processes help researchers conduct research studies on synthetic genetics, enabling them modulate gene expressions. For decades, transfection techniques are used as viable analytical tools to facilitate the study